Form 4: Heartflow Director Acquires Stock Options

Heartflow, Inc. director William C. Weldon acquired 16,075 stock options with an exercise price of $32.05, vesting in 2027.

Summary

• William C. Weldon, a Director at Heartflow, Inc., was granted 16,075 stock options on June 16, 2026.
• The exercise price for these options is $32.05 per share.
• These options are set to vest in full on the earlier of the day prior to Heartflow's annual shareholder meeting in 2027 or the first anniversary of the grant date, contingent on continued service.
• The underlying securities for these options are Heartflow, Inc. Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director, which is a routine event and does not inherently signal positive or negative performance.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The grant of options indicates a long-term incentive structure for management and directors.

Risks

• The value of the stock options is directly tied to the future performance and stock price of Heartflow, Inc.
• Vesting is contingent on continued service, meaning the options could be forfeited if the director leaves the company before the vesting date.

Future Outlook

The stock options are exercisable with an expiration date of June 16, 2036, and will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and medical technology sectors, aligning executive incentives with shareholder value creation. This filing for Heartflow, Inc. (HTFL) is typical for a company in this space.

Stakeholder Impact

• Shareholders: The issuance of options does not immediately dilute share count but could lead to dilution if exercised. It also aligns director incentives with long-term shareholder value.
• Employees: This filing does not directly impact employees, but it reflects a standard compensation practice within the company.
• Management: The director receives an incentive tied to company performance.

Next Steps

• William C. Weldon may exercise the stock options after they vest.
• The options will expire on June 16, 2036, if not exercised.

Key Dates

Keywords

Heartflow, Inc., HTFL, Form 4, Stock Options, Director, Beneficial Ownership, Securities, SEC Filing